Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Jefferies Initiates Greggs, Games Workshop

Thu, 28th May 2020 09:37

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

UBS RAISES BURBERRY PRICE TARGET TO 983 (959) PENCE - 'SELL'

----------

KEPLER CHEUVREUX CUTS VODAFONE PRICE TARGET TO 170 (175) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES HARGREAVES LANSDOWN TARGET TO 1380 (1225) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY RAISES EXPERIAN TARGET TO 2440 (2400) PENCE - 'EQUAL-WEIGHT'

----------

DEUTSCHE BANK CUTS BRITISH LAND CO PRICE TARGET TO 475 (550) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES M&G PRICE TARGET TO 210 (200) PENCE - 'BUY'

----------

BARCLAYS RAISES INTERMEDIATE CAPITAL TARGET TO 1520 (1470) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES CRODA INTERNATIONAL TARGET TO 4100 (3900) PENCE - 'UNDERPERFORM'

----------

FTSE 250

----------

JEFFERIES INITIATES GREGGS WITH 'BUY' - TARGET 2375 PENCE

----------

JEFFERIES INITIATES GAMES WORKSHOP GROUP WITH 'BUY' - TARGET 8500 PENCE

----------

JEFFERIES RAISES BRITVIC PRICE TARGET TO 850 (800) PENCE - 'BUY'

----------

JEFFERIES CUTS BEAZLEY PRICE TARGET TO 500 (575) PENCE - 'BUY'

----------

LIBERUM RAISES PAYPOINT PRICE TARGET TO 1000 (800) PENCE - 'BUY'

----------

DAVY RAISES TRAVIS PERKINS TO 'NEUTRAL' ('UNDERPERFORM')

----------

BARCLAYS CUTS TATE & LYLE PRICE TARGET TO 730 (800) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS PROVIDENT FINANCIAL TARGET TO 405 (510) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES HAYS TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 120 (105) P

----------

RBC CUTS PROVIDENT FINANCIAL PRICE TARGET TO 195 (210) PENCE - 'SECTOR PERFORM'

----------

OTHER MAIN MARKET AND AIM

----------

JPMORGAN CUTS DAILY MAIL PRICE TARGET TO 800 (950) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE CUTS DAILY MAIL PRICE TARGET TO 708 (757) PENCE - 'NEUTRAL'

----------

LIBERUM RAISES CLINIGEN PRICE TARGET TO 1050 (850) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
14 Jul 2020 09:07

Clinigen FY revenues continue to rise, profit growth slowed by Covid-19

(Sharecast News) - Pharmaceutical group Clinigen warned full-year profit growth would be at the lower end of guidance as a result of the Covid-19 pandemic and the launch of a low-cost competitor to its Foscavir drug.

Read more
13 Jul 2020 16:29

Clinigen gets orphan drug designation for 'aldesleukin' in the US

(Sharecast News) - Pharmaceutical services company Clinigen Group announced on Monday that the US Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has granted orphan drug designation for 'aldesleukin', in the treatment of amyotrophic lateral sclerosis (ALS).

Read more
13 Jul 2020 13:48

Monday broker round-up

(Sharecast News) - Kingfisher: RBC Capital Markets reiterates outperform with a target price of 275.0p

Read more
13 Jul 2020 08:41

Clinigen Gets US Orphan Drug Designation For ALS Treatment Aldesleukin

Clinigen Gets US Orphan Drug Designation For ALS Treatment Aldesleukin

Read more
14 Jun 2020 19:22

Sunday newspaper round-up: Two meters, Rolls Royce, Clinigen

(Sharecast News) - Senior scientists have reported flaws in an influential World Health Organization-commissioned study into the risks of coronavirus infection and say it should not be used as evidence for relaxing the UK's 2-metre physical distancing rule. Critics of the distancing advice, which states that people should keep at least 2 metres apart, believe it is too cautious. They seized on the research commissioned by the WHO, which suggested a reduction from 2 metres to 1 would raise infection risk only marginally, from 1.3% to 2.6%. - Guardian

Read more
28 May 2020 13:34

Thursday broker round-up

(Sharecast News) - Provident Financial: RBC Capital Markets reiterates sector performer with a target price of 195p.

Read more
26 May 2020 17:50

Clinigen Chair Leaves Audit Committee After Shareholder Engagement

Clinigen Chair Leaves Audit Committee After Shareholder Engagement

Read more
12 May 2020 10:37

McCarthy & Stone CFO Rowan Baker Defects To Laing O'Rourke

McCarthy & Stone CFO Rowan Baker Defects To Laing O'Rourke

Read more
16 Apr 2020 12:00

Clinigen Says Annual Trading In Line; Signs Erwinase License Agreement

Clinigen Says Annual Trading In Line; Signs Erwinase License Agreement

Read more
24 Mar 2020 16:00

DIRECTOR DEALINGS SUMMARY: Pearson And IHG Chairs Buy Amid Virus Pain

DIRECTOR DEALINGS SUMMARY: Pearson And IHG Chairs Buy Amid Virus Pain

Read more
20 Mar 2020 09:49

UK BROKER RATINGS SUMMARY: BHP Gets Upgrades From JPMorgan, Deutsche

UK BROKER RATINGS SUMMARY: BHP Gets Upgrades From JPMorgan, Deutsche

Read more
18 Mar 2020 13:42

Wednesday broker round-up

(Sharecast News) - Polypipe: Deutsche Bank upgrades to buy with a target price of 550p.

Read more
12 Mar 2020 16:05

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
11 Mar 2020 13:37

Wednesday broker round-up

(Sharecast News) - Clinigen Group: Liberum upgrades to buy with a target price of 780.0p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.